AbbVie lifts 2026 EPS guidance, closes Apogee deal, posts Skyrizi and Juvmo approvalsNov 12M&AAbbVieBiovie Inc.Updated
Supernus stock to delist from Nasdaq after merger closesNov 2Exchange listingSupernus Pharmaceuticals, Inc.
Artiva Biotherapeutics halts AlloNK development, cuts staff by 94%Oct 27Quarterly updateArtiva Biotherapeutics, Inc.Biogen
Supernus terminates UBS credit line ahead of Indivior merger closeOct 26M&ASupernus Pharmaceuticals, Inc.
Supernus gets orphan exclusivity for ONAPGO, files sNDA for second supplierOct 21Quarterly updateapomorphineSupernus Pharmaceuticals, Inc.Updated
Supernus and Indivior detail merger of equals in August 3 investor presentationAug 3M&ASupernus Pharmaceuticals, Inc.
Supernus and Indivior agree to merge as Supernus reports second-quarter growthAug 3Quarterly updateSupernus Pharmaceuticals, Inc.
Supernus sets August 4 date for second-quarter 2026 resultsJul 22Quarterly updateSupernus Pharmaceuticals, Inc.